Regional changes of placental vascularization in preeclampsia: A review

IUBMB Life

Volumn 67, Issue 8, 2015, Pages 619-625

  Sahay, Akriti S ^a   Sundrani, Deepali P ^a   Joshi, Sadhana R ^a  

^a Bharati Vidyapeeth   (India)

Author keywords

angiogenic factors; MMPs; neurotrophins; placenta; preeclampsia

Indexed keywords

ANGIOGENIC FACTOR; MATRIX METALLOPROTEINASE; NEUROTROPHIN;

ANGIOGENESIS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION; FEMALE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84940459073     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1407     Document Type: Review

References (80)

1. Myatt, L., (2002) Role of placenta in preeclampsia. Endocrine 19, 103-111.
2. Belkacemi, L., Nelson, D. M., Desai, M., and, Ross, M. G., (2010) Maternal undernutrition influences placental-fetal development. Biol. Reprod. 83, 325-331.
3. Al-Jameil, N., Aziz Khan, F., Fareed Khan, M., and, Tabassum, H., (2014) A brief overview of preeclampsia. J. Clin. Med. Res. 6, 1-7.
4. Zygmunt, M., Herr, F., Munstedt, K., Lang, U., and, Liang, O. D., (2003) Angiogenesis and vasculogenesis in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 110 (Suppl 1), S10-S18.
5. Levine, R. J., Maynard, S. E., Qian, C., Lim, K. H., England, L. J., et al., (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683.
6. Kulkarni, A. V., Mehendale, S. S., Yadav, H. R., Kilari, A. S., Taralekar, V. S., et al., (2010) Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens. Res. 33, 561-567.
7. Sahay, A. S., Patil, V. V., Sundrani, D. P., Joshi, A. A., Wagh, G. N., et al., (2014) A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertens. Res. 37, 753-758.
8. Sundrani, D. P., Reddy, U. S., Joshi, A. A., Mehendale, S. S., Chavan-Gautam, P. M., et al., (2013) Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin. Epigenet. 5, 6.
9. Jauniaux, E., Hempstock, J., Greenwold, N., and, Burton, G. J., (2003) Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am. J. Pathol. 162, 115-125.
10. Wyatt, S. M., Kraus, F. T., Roh, C. R., Elchalal, U., Nelson, D. M., et al., (2005) The correlation between sampling site and gene expression in the term human placenta. Placenta 26, 372-379.
11. James, J. L., Carter, A. M., and, Chamley, L. W., (2012) Human placentation from nidation to 5 weeks of gestation. I. What do we know about formative placental development following implantation? Placenta 33, 327-334.
12. Parham, P., (2004) NK cells and trophoblasts: partners in pregnancy. J. Exp. Med. 200, 951-955.
13. Lunghi, L., Ferretti, M. E., Medici, S., Biondi, C., and, Vesce, F., (2007) Control of human trophoblast function. Reprod. Biol. Endocrinol. 5, 6
14. Geva, E., Ginzinger, D. G., Zaloudek, C. J., Moore, D. H., Byrne, A., et al., (2002) Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J. Clin. Endocrinol. Metab. 87, 4213-4224.
15. Hustin, J., and, Schaaps, J. P., (1987) Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am. J. Obstet. Gynecol. 157, 162-168.
16. Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N., and, Jauniaux, E., (2002) Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 87, 2954-2959.
17. James, J. L., Stone, P. R., and, Chamley, L. W., (2006) The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum. Reprod. Update 12, 137-144.
18. Wang, A., Rana, S., and, Karumanchi, S. A., (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda, MD) 24, 147-158.
19. Furuya, M., Ishida, J., Aoki, I., and, Fukamizu, A., (2008) Pathophysiology of placentation abnormalities in pregnancy-induced hypertension. Vasc. Health Risk Manage. 4, 1301-1313.
20. Reynolds, L. P., and, Redmer, D. A., (2001) Angiogenesis in the placenta. Biol. Reprod. 64, 1033-1040.
21. Matijevic, R., Meekins, J. W., Walkinshaw, S. A., Neilson, J. P., and, McFadyen, I. R., (1995) Spiral artery blood flow in the central and peripheral areas of the placental bed in the second trimester. Obstet. Gynecol. 86, 289-292.
22. Shimo, T., Kubota, S., Kondo, S., Nakanishi, T., Sasaki, A., et al., (2001) Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett. 174, 57-64.
23. Burton, G. J., (2009) Oxygen, the Janus gas; its effects on human placental development and function. J. Anat. 215, 27-35.
24. Burton, G. J., and, Jauniaux, E., (2011) Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 287-299.
25. Hempstock, J., Bao, Y. P., Bar-Issac, M., Segaren, N., Watson, A. L., et al., (2003) Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placenta. Placenta 24, 517-523.
26. Mistry, H. D., Kurlak, L. O., Williams, P. J., Ramsay, M. M., Symonds, M. E., et al., (2010) Differential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal and preeclamptic pregnancy. Placenta 31, 401-408.
27. Roland, L., Beauchemin, D., Acteau, G., Fradette, C., St. Pierre, I., et al., (2010) Effects of labor on placental expression of superoxide dismutases in preeclampsia. Placenta 31, 392-400.
28. Abdulsid, A., and, Lyall, F., (2014) Heat shock protein 27 expression is spatially distributed in human placenta and selectively regulated during preeclampsia. J. Reprod. Immunol. 101/102, 89-95.
29. Sala, M. A., and, Matheus, M., (1986) Regional variation of the vasculo-syncytial membranes in the human full-term placenta. Gegenbaurs Morphol. Jahrb. 132, 285-289.
30. Brameld, J. M., Hold, R., and, Pipkin, F. B., (2011) Regional variation in angiotensin converting enzyme activity in the human placenta. Placenta 32, 906-908.
31. Tzschoppe, A. A., Struwe, E., Dorr, H. G., Goecke, T. W., Beckmann, M. W., et al., (2010) Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 31, 178-185.
32. Memon, N., Bircsak, K. M., Archer, F., Gibson, C. J., Ohman-Strickland, P., et al., (2014) Regional expression of the BCRP/ABCG2 transporter in term human placentas. Reprod. Toxicol. 43, 72-77.
33. Sahay, A. S., Sundrani, D. P., Wagh, G. N., Mehendale, S. S., and, Joshi, S. R., (2015) Regional differences in the placental levels of oxidative stress markers in pre-eclampsia. Int. J. Gynaecol. Obstet. 129, 213-218.
34. Kundu, S., Tyagi, N., Sen, U., and, Tyagi, S. C., (2009) Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol. Cell. Biochem. 332, 215-224.
35. Sundrani, D., Chavan-Gautam, P., Pisal, H., Mehendale, S., and, Joshi, S., (2013) Matrix metalloproteinases-2, -3 and tissue inhibitors of metalloproteinases-1, -2 in placentas from preterm pregnancies and their association with one-carbon metabolites. Reproduction 145, 401-410.
36. Wu, A., Ying, Z., and, Gomez-Pinilla, F., (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur. J. Neurosci. 19, 1699-1707.
37. Jones, R. L., Findlay, J. K., Farnworth, P. G., Robertson, D. M., Wallace, E., et al., (2006) Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 147, 724-732.
38. Naruse, K., Lash, G. E., Innes, B. A., Otun, H. A., Searle, R. F., et al., (2009) Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum. Reprod. (Oxford, England) 24, 553-561.
39. Woessner, J. F., Jr,. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
40. Zhu, J. Y., Pang, Z. J., and, Yu, Y. H., (2012) Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev. Obstet. Gynecol. 5, e137-e143.
41. Husslein, H., Haider, S., Meinhardt, G., Prast, J., Sonderegger, S., et al., (2009) Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. Placenta 30, 284-291.
42. Shokry, M., Omran, O. M., Hassan, H. I., Elsedfy, G. O., and, Hussein, M. R., (2009) Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas: preliminary findings. Exp. Mol. Pathol. 87, 219-225.
43. Zhu, J., Zhong, M., Pang, Z., and, Yu, Y., (2014) Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction. Early Hum. Dev. 90, 657-664.
44. Benyo, D. F., Smarason, A., Redman, C. W., Sims, C., and, Conrad, K. P., (2001) Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86, 2505-2512.
45. Anacker, J., Segerer, S. E., Hagemann, C., Feix, S., Kapp, M., et al., (2011) Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol. Hum. Reprod. 17, 637-652.
46. Onogi, A., Naruse, K., Sado, T., Tsunemi, T., Shigetomi, H., et al., (2011) Hypoxia inhibits invasion of extravillous trophoblast cells through reduction of matrix metalloproteinase (MMP)-2 activation in the early first trimester of human pregnancy. Placenta 32, 665-670.
47. Matjila, M., Millar, R., van der Spuy, Z., and, Katz, A., (2013) The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development. PLoS One 8, e63574
48. Demir-Weusten, A. Y., Seval, Y., Kaufmann, P., Demir, R., Yucel, G., et al., (2007) Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem. 109, 403-412.
49. Caporali, A., and, Emanueli, C., (2009) Cardiovascular actions of neurotrophins. Physiol. Rev. 89, 279-308.
50. Toti, P., Ciarmela, P., Florio, P., Volpi, N., Occhini, R., et al., (2006) Human placenta and fetal membranes express nerve growth factor mRNA and protein. J. Endocrinol. Invest. 29, 337-341.
51. Kawamura, K., Kawamura, N., Sato, W., Fukuda, J., Kumagai, J., et al., (2009) Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology 150, 3774-3782.
52. Kawamura, K., Kawamura, N., Fukuda, J., Kumagai, J., Hsueh, A. J., et al., (2007) Regulation of preimplantation embryo development by brain-derived neurotrophic factor. Dev. Biol. 311, 147-158.
53. Fujita, K., Tatsumi, K., Kondoh, E., Chigusa, Y., Mogami, H., et al., (2011) Differential expression and the anti-apoptotic effect of human placental neurotrophins and their receptors. Placenta 32, 737-744.
54. Chouthai, N. S., Sampers, J., Desai, N., and, Smith, G. M., (2003) Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr. Res. 53, 965-969.
55. Mayeur, S., Lukaszewski, M. A., Breton, C., Storme, L., Vieau, D., et al., (2011) Do neurotrophins regulate the feto-placental development? Med. Hypotheses 76, 726-728.
56. Bienertova-Vasku, J., Bienert, P., Zlamal, F., Splichal, Z., Tomandl, J., et al., (2013) Brain-derived neurotrophic factor and ciliary neurotrophic factor in maternal plasma and umbilical cord blood from pre-eclamptic and physiological pregnancies. J. Obstet. Gynaecol. 33, 359-363.
57. Casciaro, A., Arcuri, F., Occhini, R., Toti, M. S., De Felice, C., et al., (2009) Expression of placental neurotrophin-3 (NT-3) in physiological pregnancy, preeclampsia and chorioamnionitis. Clin. Med. Pathol. 2, 9-15.
58. Frank, P., Barrientos, G., Tirado-Gonzalez, I., Cohen, M., Moschansky, P., et al., (2014) Balanced levels of nerve growth factor are required for normal pregnancy progression. Reproduction 148, 179-189.
59. Malamitsi-Puchner, A., Nikolaou, K. E., and, Puchner, K. P., (2006) Intrauterine growth restriction, brain-sparing effect, and neurotrophins. Ann. NY Acad. Sci. 1092, 293-296.
60. Sahay, A. S., Sundrani, D. P., Wagh, G. N., Mehendale, S. S., and, Joshi, S. R., (2015) Neurotrophin levels in different regions of the placenta and their association with birth outcome and blood pressure. Placenta, pii: S0143-4004(15)00956-X.
61. Lewin, G. R., and, Barde, Y. A., (1996) Physiology of the neurotrophins. Ann. Rev. Neurosci. 19, 289-317.
62. Zacchigna, S., Lambrechts, D., and, Carmeliet, P., (2008) Neurovascular signalling defects in neurodegeneration. Nat. Rev. Neurosci. 9, 169-181.
63. Nico, B., Mangieri, D., Benagiano, V., Crivellato, E., and, Ribatti, D., (2008) Nerve growth factor as an angiogenic factor. Microvasc. Res. 75, 135-141.
64. Julio-Pieper, M., Lozada, P., Tapia, V., Vega, M., Miranda, C., et al., (2009) Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a TrkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway. J. Clin. Endocrinol. Metab. 94, 3065-3071.
65. Calza, L., Giardino, L., Giuliani, A., Aloe, L., and, Levi-Montalcini, R., (2001) Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc. Natl. Acad. Sci. USA 98, 4160-4165.
66. Cantarella, G., Lempereur, L., Presta, M., Ribatti, D., Lombardo, G., et al., (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 16, 1307-1309.
67. Nakamura, K., Martin, K. C., Jackson, J. K., Beppu, K., Woo, C. W., et al., (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells. Cancer Res. 66, 4249-4255.
68. Rundhaug, J. E., (2005) Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9, 267-285.
69. Fang, C., Wen, G., Zhang, L., Lin, L., Moore, A., et al., (2013) An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovasc. Res. 99, 146-155.
70. Heo, S. H., Choi, Y. J., Ryoo, H. M., and, Cho, J. Y., (2010) Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. J. Cell. Physiol. 224, 734-742.
71. Li, W., Mata, K. M., Mazzuca, M. Q., and, Khalil, R. A., (2014) Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochem. Pharmacol. 89, 370-385.
72. Park, M. J., Kwak, H. J., Lee, H. C., Yoo, D. H., Park, I. C., et al., (2007) Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. J. Biol. Chem. 282, 30485-30496.
73. Lin, C. Y., Chang, S. L., Fong, Y. C., Hsu, C. J., and, Tang, C. H., (2013) Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells. Int. J. Mol. Sci. 14, 15459-15478.
74. Blanco-Mezquita, T., Martinez-Garcia, C., Proenca, R., Zieske, J. D., Bonini, S., et al., (2013) Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9. Invest. Ophthalmol. Vis. Sci. 54, 3880-3890.
75. Kuzniewska, B., Rejmak, E., Malik, A. R., Jaworski, J., Kaczmarek, L., et al., (2013) Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway. Mol. Cell. Biol. 33, 2149-2162.
76. Ferreira, I., Peeters, L. L., and, Stehouwer, C. D., (2009) Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J. Hypertens. 27, 1955-1959.
77. Kajantie, E., Eriksson, J. G., Osmond, C., Thornburg, K., and, Barker, D. J., (2009) Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 40, 1176-1180.
78. Giguere, Y., Charland, M., Theriault, S., Bujold, E., Laroche, M., et al., (2012) Linking preeclampsia and cardiovascular disease later in life. Clin. Chem. Lab. Med. 50, 985-993.
79. Smith, G. N., Pudwell, J., Walker, M., and, Wen, S. W., (2012) Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J. Obstet. Gynaecol. Can. 34, 836-841.
80. Hakim, J., Senterman, M. K., and, Hakim, A. M., (2013) Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system. Int. J. Pediatr. 2013, 953150